Flexion Therapeutics, Inc. Operating Lease Cost
Flexion Therapeutics, Inc. reported Operating Lease Cost of $586.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2021-11-12
- Flexion Therapeutics, Inc. operating lease, cost for the quarter ending 2021-09-30 was $586.00K, a 2.63% increase year-over-year.
- Flexion Therapeutics, Inc. operating lease, cost for the quarter ending 2021-06-30 was $576.00K, a 1.23% increase year-over-year.
- Flexion Therapeutics, Inc. operating lease, cost for the quarter ending 2021-03-31 was $575.00K, a 0.88% increase year-over-year.
- Flexion Therapeutics, Inc. operating lease, cost for the quarter ending 2020-12-31 was $573.00K, a 0.35% increase year-over-year.
- Flexion Therapeutics, Inc. operating lease, cost for fiscal 2020 was $2.28M, a 16.00% increase from fiscal 2019.
- Flexion Therapeutics, Inc. operating lease, cost for fiscal 2019 was $1.97M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-09-30 | $586.00K 10-Q · filed 2021-11-12 | $1.16M derived: sum of 2 quarters · filed 2021-11-12 | $1.74M 10-Q · filed 2021-11-12 | $2.31M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $576.00K 10-Q · filed 2021-08-04 | $1.15M 10-Q · filed 2021-08-04 | $1.72M derived: sum of 3 quarters · filed 2021-08-04 | $2.29M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $575.00K 10-Q · filed 2021-05-12 | $1.15M derived: sum of 2 quarters · filed 2021-05-12 | $1.72M derived: sum of 3 quarters · filed 2021-11-12 | $2.29M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $1.14M derived: sum of 2 quarters · filed 2021-11-12 | $1.71M derived: sum of 3 quarters · filed 2021-11-12 | $2.28M 10-K · filed 2021-03-10 |
| 2020-09-30 | $571.00K 10-Q · filed 2021-11-12 | $1.14M derived: sum of 2 quarters · filed 2021-11-12 | $1.71M 10-Q · filed 2021-11-12 | $2.28M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $569.00K 10-Q · filed 2021-08-04 | $1.14M 10-Q · filed 2021-08-04 | $1.71M derived: sum of 3 quarters · filed 2021-08-04 | $2.28M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $570.00K 10-Q · filed 2021-05-12 | $1.14M derived: sum of 2 quarters · filed 2021-05-12 | $1.71M derived: sum of 3 quarters · filed 2021-05-12 | $2.13M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $1.14M derived: sum of 2 quarters · filed 2021-03-10 | $1.55M derived: sum of 3 quarters · filed 2021-03-10 | $1.97M 10-K · filed 2021-03-10 |
| 2019-09-30 | $567.00K 10-Q · filed 2020-11-04 | $984.00K derived: sum of 2 quarters · filed 2020-11-04 | $1.40M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $417.00K 10-Q · filed 2020-08-05 | $831.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $414.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $1.10M 8-K · filed 2020-05-20 | |||
| 2017-12-31 | $1.00M 8-K · filed 2020-05-20 |